Investcorp Private Equity Fund II files SEBI Reg 31(4) substantial acquisition disclosure for Nephrocare Health Services

M&A / JV 18 Jun 2026 · Filed / open· ✓ Verified

The disclosure filed with the NSE under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Regulation 31(4) indicates that Investcorp Private Equity Fund II has initiated a substantial shareholding or control acquisition in Nephrocare Health Services Limited. The timing (June 2026) and regulatory mechanism used suggest a structured acquisition likely subject to conditions precedent (regulatory clearances including CCI, FIPB if applicable, and SEBI approval of open offer if triggered). The specific acquisition value, percentage stake, and timing to completion are contained in the full disclosure document filed with the exchange.

Why it mattersSEBI Reg 31(4) filings trigger mandatory disclosure of shareholding ≥25% and takeover intent; this filing marks the public announcement phase of the acquisition and may precede an open offer if crossing the 25% threshold or acquisition of control.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals